edoc

Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa

Widmer, Lukas L. and Blank, Patricia R. and Van Herck, Koen and Hatz, Christoph and Schlagenhauf, Patricia. (2010) Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. BMC infectious diseases, Vol. 10. p. 279.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6003452

Downloads: Statistics Overview

Abstract

The importation of malaria to non-endemic countries remains a major cause of travel-related morbidity and a leading cause of travel-related hospitalizations. Currently they are three priority medications for malaria prophylaxis to West Africa: mefloquine, atovaquone/proguanil and doxycycline. We investigate the cost effectiveness of a partial reimbursement of the cheapest effective malaria chemoprophylaxis (mefloquine) for travellers to high risk areas of malaria transmission compared with the current situation of no reimbursement.
Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:Blank, Patricia R.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:BioMed Central
ISSN:1471-2334
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:08 Nov 2012 16:23
Deposited On:08 Nov 2012 16:21

Repository Staff Only: item control page